Home > Cashflow Statement > AMBALAL SARABHAI ENTERPRISES

AMBALAL SARABHAI ENTERPRISES
Cashflow Statement

AMBALAL SARABHAI ENTERPRISES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

AMBALAL SARABHAI ENTERPRISES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹4.83 Cr₹6.65 Cr₹15 Cr₹54 Cr₹33 Cr
Adjustment ₹2.21 Cr₹4.47 Cr₹-0.60 Cr₹-20 Cr₹-25 Cr
Changes In working Capital ₹-21 Cr₹1.77 Cr₹-4.43 Cr₹-19 Cr₹-7.96 Cr
Cash Flow after changes in Working Capital ₹-14 Cr₹13 Cr₹10 Cr₹15 Cr₹-0.34 Cr
Cash Flow from Operating Activities ₹-18 Cr₹8.89 Cr₹5.72 Cr₹11 Cr₹-2.30 Cr
Cash Flow from Investing Activities ₹13 Cr₹-5.30 Cr₹-17 Cr₹5.08 Cr₹10 Cr
Cash Flow from Financing Activities ₹-1.53 Cr₹-2.95 Cr₹9.09 Cr₹-19 Cr₹-5.84 Cr
Net Cash Inflow / Outflow ₹-5.88 Cr₹0.65 Cr₹-1.97 Cr₹-2.64 Cr₹1.95 Cr
Opening Cash & Cash Equivalents ₹11 Cr₹10 Cr₹12 Cr₹15 Cr₹13 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹4.89 Cr₹11 Cr₹10 Cr₹12 Cr₹15 Cr

Compare Cashflow Statement of peers of AMBALAL SARABHAI ENTERPRISES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AMBALAL SARABHAI ENTERPRISES ₹202.8 Cr -5.5% 1.5% -45.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AMBALAL SARABHAI ENTERPRISES

-5.5%

1.5%

-45.1%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses